VAERS reports by lot

GSK Varicella/Shingles lot 272M2: VAERS reports

27 VAERS reports list lot 272M2 as a GSK Varicella/Shingles vaccine, received between 2020-04-08 and 2021-07-05. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
27
Reports
7%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3730%
Injection-site / Local reaction2822%
Neurological2419%
Gastrointestinal1210%
Musculoskeletal97%
Dermatological (non-injection-site)86%
Cardiac / Cardiovascular32%
Allergic / Anaphylactic32%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania4
Washington3
Nevada2
Ohio2
Texas2
Florida2
Arizona2
New York1
New Hampshire1
Delaware1
Virginia1
New Jersey1

Reports by month received

2020-043
2020-052
2020-067
2020-074
2020-084
2020-092
2020-102
2020-111
2020-121
2021-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.